Medical Thoracoscopy for Undiagnosed Transudative & Exudative Pleural

Status Not yet recruiting

Clinical Trial Summary

Indonesia is one of country that contributes the most cases of tuberculosis worldwide. Tuberculosis is the most commonly etiology of exudative pleural effusion. There have been many studies about undiagnosed exudative pleural effusions, but there are not many studies about the use of medical thoracoscopy for diagnosing transudative and exudative pleural effusion, especially on biomarkers of C-Reactive Protein (CRP), D-dimer, Adenosine Deaminase (ADA), Antinuclear Antibody (ANA), C3 C4 complements, Cancer Antigen 125 (CA-125), Xpert Mycobacterium Tuberculosis (Xpert MTB), Lupus Erythematosus cell (LE cell), cytology (effusion and smear) and histopathology. Information gained from those biomarkers via thoracocentesis and medical thoracoscopy, etiology of exudative and transudative pleural effusion can be detected earlier and clearly, especially etiology of infection, autoimmune, and malignancy that further can be used to reduce patients' hospitalization period, mortality, and to develop the new therapeutic agents.

Clinical Trial Description

Medical thoracoscopy is a minimally invasive procedure to access pleura with combination of visual and medical instrument. The procedure is performed under local anesthesia and conscious sedation. Medical thoracoscopy plays role in basic diagnostic and therapeutic. The most common indication on basic diagnostic is on pleural effusion case that has primary target to get specific diagnosis when the etiology of pleural effusion is unknown. Pleural effusion is fluid accumulation inside the pleura for about 15-20 ml. Primary aim of pleural effusion diagnosis is to differentiate exudative and transudative effusions based on Light Criteria. Most of time thoracentesis cannot give etiology of exudative and transudative pleural effusion. Researchers will evaluate subjects based on inclusion and exclusion criteria in Cipto Mangunkusumo Hospital. Research subjects will be asked for informed consent. Furthermore, data will be collected based on research form. Researchers will perform medical thoracoscopy to take specimen for analysing CRP, D-dimer, ADA, ANA, C3 C4 complements, Xpert MTB, LE cell, cytology (effusion and smear) and histopathology to detect the etiology of tuberculosis, malignancy or autoimmune. ;

Study Design

Related Conditions & MeSH terms

Pleural Effusion

Clinical Trial Details

NCT number	NCT05553665
Study type	Interventional
Source	Indonesia University
Contact	Gurmeet Singh, MD, PhD
Phone	+6281385158159
Email	gurmeetsingh10@yahoo.com
Status	Not yet recruiting
Phase	N/A
Start date	November 1, 2022
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04159831` - A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions	Phase 2
Recruiting	`NCT02891642` - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT02045641` - Pleural and Pericardial Effusion Following Open Heart Surgery	N/A
Completed	`NCT01948076` - Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination	N/A
Completed	`NCT01416519` - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation	N/A
Completed	`NCT01560078` - Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion	N/A
Completed	`NCT04891705` - Point of Care Ultrasound Lung Artificial Intelligence (AI) Validation Data Collection Study
Recruiting	`NCT05759117` - Prospective Evaluation of Patients With Pleural Effusion
Recruiting	`NCT05910112` - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed	`NCT03896672` - Clinical Implementation of the Use of Positive Pressure in Chest Drainage	N/A
Active, not recruiting	`NCT06075836` - AI Assisted Detection of Chest X-Rays
Recruiting	`NCT03728491` - Education and Training Competences in Thoracic Ultrasound	N/A
Completed	`NCT03535883` - The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
Not yet recruiting	`NCT03260088` - Evaluation Of Pleural Effusion At Assiut University Hospital	N/A
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT03661801` - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Completed	`NCT01778270` - Not Invasive Monitoring of Pleural Drainage	N/A
Terminated	`NCT00402896` - Malignant Pleural Effusion With ZD6474	Phase 2
Recruiting	`NCT00103766` - Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Medical Thoracoscopy for Undiagnosed Transudative and Exudative Pleural Effusions

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms